https://plerixafor.com/index.p....hp/optimum-re-re-als
All articles published from 1 January 1990 as much as 19 February 2018 in MEDLINE of PubMed, EMBASE, the Cochrane Library and LILACS databases had been searched. An overall total of 120 articles had been selected for evaluation, comprising 6419 patients addressed with lamivudine (LAM), 5947 with entecavir (ETV), 3566 with tenofovir disoproxil fumarate (TDF), 3096 with telbivudine (LdT), 1178 with adefovir dipivoxil (ADV) and 876 with tenofovir alafenamide (TAF). The most common AEs in most NAs evaluated were stomach pain/discom
Like
Comment
Share
